Vivani Medical, Inc. (NASDAQ:VANI – Get Free Report) was the recipient of a significant decline in short interest in April. As of April 15th, there was short interest totalling 589,100 shares, a decline of 32.4% from the March 31st total of 871,100 shares. Approximately 2.0% of the shares of the stock are short sold. Based on an average daily trading volume, of 3,010,000 shares, the short-interest ratio is presently 0.2 days.
Vivani Medical Stock Down 3.8 %
Shares of Vivani Medical stock opened at $1.63 on Friday. The firm’s 50-day moving average price is $1.93 and its two-hundred day moving average price is $1.33. Vivani Medical has a 1-year low of $0.84 and a 1-year high of $7.80.
Vivani Medical (NASDAQ:VANI – Get Free Report) last released its quarterly earnings results on Tuesday, March 26th. The company reported ($0.12) EPS for the quarter.
Vivani Medical Company Profile
Vivani Medical, Inc, a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals.
Featured Articles
- Five stocks we like better than Vivani Medical
- Why Invest in High-Yield Dividend Stocks?
- MarketBeat Week in Review – 4/22 – 4/26
- Using the MarketBeat Dividend Tax Calculator
- 3 Stocks Leading the U.S. Agriculture Comeback
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- How to Use Put Debit Spreads to Profit From Falling Stocks
Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.
